Search results
Apr 15, 2021 · Molecular and antigen tests can detect current SARS-CoV-2 infection and are used to diagnose COVID-19. Clinicians should consider a test's characteristics, test timing in relation to symptom onset ...
COVID-19 Positive (SARS-CoV-2 RNA Detected) Test Result. If your COVID-19 test was positive, this means that the test did detect the presence of COVID-19 in your nasal secretions. This result would suggest that you are currently infected with COVID-19. If you had a positive COVID-19 test, please self-isolate at home as much as possible ...
Jan 9, 2024 · Testing for SARS-CoV-2 Infection Test Types. Viral tests, including nucleic acid amplification tests (NAATs, such as PCR tests), antigen tests and other tests (such as breath tests) are used as diagnostic tests to detect current infection with SARS-CoV-2, determine the need for prevention measures like isolation, and inform an individual’s medical care.
SARS-CoV-2 RT-PCR is the primary diagnostic test for COVID-19 (Medicare reimbursement, $75). The test amplifies targeted nucleic acid sequences to detect SARS-CoV-2 RNA. RT-PCR testing detects SARS-CoV-2 RNA at low levels, with analytic sensitivity of 98% and specificity of 97%. 2 Analytic sensitivity and specificity refer to RT-PCR detection ...
- K C Coffey, Daniel J Diekema, Daniel J Morgan
- 2021
May 12, 2023 · Updates as of June 16, 2021. Clarified the differences between laboratory-based and point-of-care NAATs. A Nucleic Acid Amplification Test, or NAAT, is a type of viral diagnostic test for SARS-CoV-2, the virus that causes COVID-19. NAATs detect genetic material (nucleic acids). NAATs for SARS-CoV-2 specifically identify the RNA (ribonucleic ...
Dec 20, 2023 · Diagnostic Testing for SARS-CoV-2 Infection. For diagnosing current SARS-CoV-2 infection, the Centers for Disease Control and Prevention (CDC) recommends using either a nucleic acid amplification test (NAAT) or an antigen test. 1 Testing may also be used for screening and to determine the length of a patient’s isolation period. 2 There may be a window period of up to 5 days after exposure ...
The procedure begins by taking a sample from a potentially infected person’s nose or mouth (saliva), where virus might be found. If SARS-CoV-2 is present in the sample, then even low levels of virus genomic material can be amplified into millions of copies detected during a molecular diagnostic assay.
